Javier Garjón

ORCID: 0000-0002-0126-7431
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical studies and practices
  • Medication Adherence and Compliance
  • Sodium Intake and Health
  • Healthcare Systems and Technology
  • Cardiac Health and Mental Health
  • Pneumonia and Respiratory Infections
  • Religious and Theological Studies
  • Helminth infection and control
  • Cardiac Arrhythmias and Treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Aortic Disease and Treatment Approaches
  • Atrial Fibrillation Management and Outcomes
  • Hormonal Regulation and Hypertension
  • Geological and Geochemical Analysis
  • Coccidia and coccidiosis research
  • Microscopic Colitis
  • Cardiac Structural Anomalies and Repair
  • Pharmaceutical industry and healthcare
  • Alcohol Consumption and Health Effects
  • Educational Innovations and Technology
  • Eicosanoids and Hypertension Pharmacology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Patient Satisfaction in Healthcare

Servicio Navarro de Salud
2009-2025

Navarre Institute of Health Research
2017-2025

Hospital Universitario Infanta Leonor
2025

Pediatric Hospital "Baca Ortiz"
2024

Comisión Nacional de Energía Atómica
2013-2024

Madrid Health Service
2020-2022

Hospital Universitario HM Madrid
2004-2022

HM Hospitales
2020

Hospital Universitario HM Sanchinarro
2020

University Hospital HM Puerta del Sur
2020

Aims To evaluate the association between use of different oral antidiabetic agents (OAD) and risk community‐acquired pneumonia (CAP) in patients with type‐2 diabetes (T2DM). Methods Case–control study nested a cohort T2DM OAD 2002 2013, based Spanish general practice research database. Cases were people diagnosed T2DM, aged >18 years validated diagnosis CAP 2013. Ten controls matched on age, sex calendar year. Odds ratio (OR) was estimated comparing treated with: (1) metformin vs. other...

10.1111/bcp.13288 article EN British Journal of Clinical Pharmacology 2017-03-11

New drugs often substitute others cheaper and with a risk-benefit balance better established. Our aim was to analyse the diffusion of new during first months use, examining differences between family physicians specialists. Prescription data were obtained cefditoren, duloxetine, etoricoxib, ezetimibe, levocetirizine, olmesartan, pregabalin tiotropium 36 after their launching. We monthly number prescriptions per doctor prescribers each drug by specialty. After discarding those less than 10...

10.1186/1472-6963-12-56 article EN cc-by BMC Health Services Research 2012-03-08

On 11 March 2020, the World Health Organization declared coronavirus disease 19 (COVID-19) a global pandemic. This exceptional situation changed world not only in terms of mortality and morbidity, but also epidemiology health system resources consumption. The objective this work was to analyze consumption antibiotics during period around pandemic our region. A drug utilization study performed comparing antibiotic community years 2018, 2019, 2021. Quarterly use (defined daily doses (DDD) per...

10.3390/antibiotics12020318 article EN cc-by Antibiotics 2023-02-03

ResumenSe presentan resultados de un trabajo docente, efectuado con el objetivo que nuestros alumnos primer año universidad adquirieran, forma sencilla y efectiva, conocimientos Química Orgánica básica.Las herramientas educativas utilizadas para la enseñanza conceptos teóricos simples complejos, están sustentadas en uso las Tecnologías Información Comunicación (TICs).Se elaboró material didáctico visual a color 2D 3D, juegos videos educativos, todos accesibles formato electrónico.Se ha...

10.4067/s0718-50062014000100005 article ES Formación universitaria 2014-01-01

Concomitant use of diuretics, renin-angiotensin-aldosterone system (RAAS) inhibitors, and non-steroidal anti-inflammatory drugs (NSAIDs) or metamizole, known as 'triple whammy' (TW), has been associated with an increased risk acute kidney injury (AKI). Nevertheless, there is still uncertainty on its impact in hospitalisation mortality. The aim the study was to analyse association between exposure TW for AKI, all-cause mortality need renal replacement therapy (RRT).

10.1002/pds.5621 article EN Pharmacoepidemiology and Drug Safety 2023-03-24

Simultaneous administration of cortisol and testosterone-4-C 14 to the rat results in a decrease concentration radioactivity several tissues similar that observed when is diluted with an equal amount nonlabeled testosterone. Estradiol, given simultaneously labeled testosterone, did not show same effect. These findings are interpreted testosterone compete for sites binding examined. The subcellular distribution muscle, kidney, liver following intravenous injection was almost identical found...

10.1152/ajplegacy.1962.202.2.340 article EN American Journal of Physiology-Legacy Content 1962-02-01

SUMMARY Oral anti-diabetic drugs (OADs) have been associated with community-acquired pneumonia (CAP). We aimed to validate the recording of CAP in Spanish Database for Pharmacoepidemiological Research Primary Care (BIFAP) future evaluation OAD–CAP association. The incidence rate (IR/1000 person-years) type 2 diabetes mellitus (T2DM) was also determined. In total, 2966 records (2040 listed as diagnosis and 926 identified from comments added by physicians) were 76 009 patients T2DM after first...

10.1017/s0950268817001868 article EN Epidemiology and Infection 2017-08-31

Unethical behaviour by any of the actors involved in edition a scientific paper can lead to miscalculation evidence synthesis indicators. More specifically, duplicate publication may incorporation false meta-analyses, which will adversely affect assessment efficacy and safety interventions.1 On other hand, redundant validity practice recommendations professional associations, usually underpin clinical practice. Systematic reviews create an excellent opportunity identify denounce fraud, as...

10.1136/bmjebm-2018-110917 article EN BMJ evidence-based medicine 2018-04-12
Coming Soon ...